We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » STUDY: LONG Rx TRIALS EQUATE TO GREATER FAILURE RATES
The item has been added to your shopping cart.
STUDY: LONG Rx TRIALS EQUATE TO GREATER FAILURE RATES
December 17, 2004
Nearly three-quarters of all investigative drugs fail to make it through clinical trials, but the chances of a particular drug reaching the market decrease as the time to complete the trials increases, according to a new study that assesses the prospects of drugs in the pipeline.